Kuo CS - Search Results

1

Sequential treatment in advanced non-small cell lung cancer harboring EGFR mutations.

Hsu PC, Chang JW, Chang CF, Huang CY, Yang CT, Kuo CS, Fang YF, Wu CE. Hsu PC, et al. Among authors: kuo cs. Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221132731. doi: 10.1177/17534666221132731. Ther Adv Respir Dis. 2022. PMID: 36305280 Free PMC article.

2

Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.

Kuo CS, Liu CY, Pavlidis S, Lo YL, Wang YW, Chen CH, Ko HW, Chung FT, Lin TY, Wang TY, Lee KY, Guo YK, Wang TH, Yang CT. Kuo CS, et al. Front Immunol. 2018 Feb 12;9:232. doi: 10.3389/fimmu.2018.00232. eCollection 2018. Front Immunol. 2018. PMID: 29483918 Free PMC article.

3

Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR-mutant and EGFR-wild type nonsquamous non-small cell lung cancer.

Huang YC, Shen SM, Liu CY, Pavlidis S, Wang CL, Ko HW, Chung FT, Lin TY, Feng PH, Lee KY, Guo YK, Yang CT, Kuo CS. Huang YC, et al. Among authors: kuo cs. Thorac Cancer. 2018 Dec;9(12):1648-1655. doi: 10.1111/1759-7714.12875. Epub 2018 Sep 27. Thorac Cancer. 2018. PMID: 30259696 Free PMC article.

4

Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer.

Kuo CS, Wang CC, Huang YC, Pavlidis S, Liu CY, Ko HW, Chung FT, Lin TY, Wang CL, Guo YK, Yang CT. Kuo CS, et al. Thorac Cancer. 2019 May;10(5):1158-1166. doi: 10.1111/1759-7714.13057. Epub 2019 Apr 5. Thorac Cancer. 2019. PMID: 30950239 Free PMC article.

5

Prior EGFR-TKI Treatment in EGFR-Mutated NSCLC Affects the Allele Frequency Fraction of Acquired T790M and the Subsequent Efficacy of Osimertinib.

Kuo CS, Huang CH, Liu CY, Pavlidis S, Ko HW, Chung FT, Lin TY, Wang CL, Guo YK, Yang CT. Kuo CS, et al. Target Oncol. 2019 Aug;14(4):433-440. doi: 10.1007/s11523-019-00657-1. Target Oncol. 2019. PMID: 31346928

6

Front-line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control.

Huang SH, Huang AC, Wang CC, Chang WC, Liu CY, Pavlidis S, Ko HW, Chung FT, Hsu PC, Guo YK, Kuo CS, Yang CT. Huang SH, et al. Among authors: kuo cs. Thorac Cancer. 2019 Dec;10(12):2274-2281. doi: 10.1111/1759-7714.13221. Epub 2019 Oct 15. Thorac Cancer. 2019. PMID: 31613427 Free PMC article.

7

Consolidation treatment of durvalumab after chemoradiation in real-world patients with stage III unresectable non-small cell lung cancer.

Chu CH, Chiu TH, Wang CC, Chang WC, Huang AC, Liu CY, Wang CL, Ko HW, Chung FT, Hsu PC, Guo YK, Kuo CS, Yang CT. Chu CH, et al. Among authors: kuo cs. Thorac Cancer. 2020 Jun;11(6):1541-1549. doi: 10.1111/1759-7714.13426. Epub 2020 Apr 13. Thorac Cancer. 2020. PMID: 32281272 Free PMC article.

8

A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.

Kuo CS, Tung PH, Huang AC, Wang CC, Chang JW, Liu CY, Chung FT, Fang YF, Guo YK, Yang CT. Kuo CS, et al. BMC Cancer. 2021 Mar 24;21(1):309. doi: 10.1186/s12885-021-08005-1. BMC Cancer. 2021. PMID: 33761908 Free PMC article.

9

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.

Wu CE, Chang CF, Huang CY, Yang CT, Kuo CS, Hsu PC, Chang JW. Wu CE, et al. Among authors: kuo cs. BMC Cancer. 2021 Jul 27;21(1):859. doi: 10.1186/s12885-021-08587-w. BMC Cancer. 2021. PMID: 34315431 Free PMC article.

10

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.

Huang AC, Huang CH, Ju JS, Chiu TH, Tung PH, Wang CC, Liu CY, Chung FT, Fang YF, Guo YK, Kuo CS, Yang CT. Huang AC, et al. Among authors: kuo cs. Ther Adv Med Oncol. 2021 Jul 31;13:17588359211035710. doi: 10.1177/17588359211035710. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34377157 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page